2018
DOI: 10.21037/atm.2018.09.06
|View full text |Cite
|
Sign up to set email alerts
|

Adult mesenchymal stem cells for the treatment in patients with rotator cuff disease: present and future direction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 41 publications
0
3
0
Order By: Relevance
“…Treatments using MSCs were not regulated by the Food and Drug Administration (FDA) until recently. MSC injections have been shown to improve tendon repair in animal models in vivo [86][87][88][89][90] and some studies have also reported beneficial effects of MSC injections on human tendon healing including pain reduction and improved healing. 91 At present, there are several ongoing clinical trials investigating whether autologous and allogeneic MSCs derived from bone marrow or adipose tissue can effectively treat tendon injuries and tendinopathies predominantly in the rotator cuff.…”
Section: Emerging Cell-based Treatments and Engineering Strategiesmentioning
confidence: 99%
“…Treatments using MSCs were not regulated by the Food and Drug Administration (FDA) until recently. MSC injections have been shown to improve tendon repair in animal models in vivo [86][87][88][89][90] and some studies have also reported beneficial effects of MSC injections on human tendon healing including pain reduction and improved healing. 91 At present, there are several ongoing clinical trials investigating whether autologous and allogeneic MSCs derived from bone marrow or adipose tissue can effectively treat tendon injuries and tendinopathies predominantly in the rotator cuff.…”
Section: Emerging Cell-based Treatments and Engineering Strategiesmentioning
confidence: 99%
“…With the development of surgical techniques, most rotator cuff tears are repaired with the arthroscopic approach. However, the tendon healing capacity decreases with age increased (2,3). Boileau et al reported that the healing rate was only 43% for patients older than 65 years after single-row repair (2).…”
Section: Introductionmentioning
confidence: 99%
“…21,73,91 Conservative treatment of RCTs typically consists of physiotherapy and exercises and may include the use of pharmacologic or biological agents, taken orally or directly administered to the tendon. 22,29,32,40 Unfortunately, such agents have limited efficacy in RCT healing. 9,18,19,33 To assist in the development of more conservative treatment agents, a better understanding of RCT pathophysiology is required.…”
mentioning
confidence: 99%